Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California. more
Time Frame | IBIO | Sector | S&P500 |
---|---|---|---|
1-Week Return | 0.43% | -0.94% | -2.6% |
1-Month Return | -7.81% | -5.08% | -1.08% |
3-Month Return | 27.57% | -10.62% | 3.45% |
6-Month Return | 12.92% | -6.18% | 8.57% |
1-Year Return | 67.38% | 1.98% | 24.3% |
3-Year Return | -99.29% | -0.93% | 25.58% |
5-Year Return | -98.07% | 33.84% | 84.07% |
10-Year Return | -99.93% | 102.52% | 185.12% |
Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 1.64M | 2.37M | 2.38M | 50.00K | 225.00K | [{"date":"2020-06-30","value":68.74,"profit":true},{"date":"2021-06-30","value":99.5,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":2.1,"profit":true},{"date":"2024-06-30","value":9.44,"profit":true}] |
Cost of Revenue | 703.00K | 1.46M | 216.00K | 1.11M | 1.25M | [{"date":"2020-06-30","value":48.08,"profit":true},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":14.77,"profit":true},{"date":"2023-06-30","value":75.65,"profit":true},{"date":"2024-06-30","value":85.5,"profit":true}] |
Gross Profit | 935.00K | 909.00K | 2.17M | 50.00K | 225.00K | [{"date":"2020-06-30","value":43.15,"profit":true},{"date":"2021-06-30","value":41.95,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":2.31,"profit":true},{"date":"2024-06-30","value":10.38,"profit":true}] |
Gross Margin | 57.08% | 38.34% | 90.94% | 100.00% | 100.00% | [{"date":"2020-06-30","value":57.08,"profit":true},{"date":"2021-06-30","value":38.34,"profit":true},{"date":"2022-06-30","value":90.94,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":100,"profit":true}] |
Operating Expenses | 15.64M | 32.02M | 51.86M | 29.34M | 16.86M | [{"date":"2020-06-30","value":30.16,"profit":true},{"date":"2021-06-30","value":61.75,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":56.58,"profit":true},{"date":"2024-06-30","value":32.51,"profit":true}] |
Operating Income | (14.00M) | (31.11M) | (49.69M) | (29.31M) | (16.63M) | [{"date":"2020-06-30","value":-1400300000,"profit":false},{"date":"2021-06-30","value":-3111100000,"profit":false},{"date":"2022-06-30","value":-4969000000,"profit":false},{"date":"2023-06-30","value":-2931100000,"profit":false},{"date":"2024-06-30","value":-1663400000,"profit":false}] |
Total Non-Operating Income/Expense | (4.89M) | 5.58M | (1.05M) | 32.00K | 1.38M | [{"date":"2020-06-30","value":-87.61,"profit":false},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":-18.8,"profit":false},{"date":"2023-06-30","value":0.57,"profit":true},{"date":"2024-06-30","value":24.75,"profit":true}] |
Pre-Tax Income | (16.44M) | (23.21M) | (50.30M) | (29.31M) | (15.44M) | [{"date":"2020-06-30","value":-1644400000,"profit":false},{"date":"2021-06-30","value":-2321300000,"profit":false},{"date":"2022-06-30","value":-5030400000,"profit":false},{"date":"2023-06-30","value":-2931100000,"profit":false},{"date":"2024-06-30","value":-1544300000,"profit":false}] |
Income Taxes | 2.47M | 46.00K | 701.00K | (1.20M) | 9.64M | [{"date":"2020-06-30","value":25.64,"profit":true},{"date":"2021-06-30","value":0.48,"profit":true},{"date":"2022-06-30","value":7.27,"profit":true},{"date":"2023-06-30","value":-12.49,"profit":false},{"date":"2024-06-30","value":100,"profit":true}] |
Income After Taxes | (18.91M) | (23.26M) | (51.01M) | (28.11M) | (25.08M) | [{"date":"2020-06-30","value":-1891500000,"profit":false},{"date":"2021-06-30","value":-2325900000,"profit":false},{"date":"2022-06-30","value":-5100500000,"profit":false},{"date":"2023-06-30","value":-2810700000,"profit":false},{"date":"2024-06-30","value":-2507900000,"profit":false}] |
Income From Continuous Operations | (16.44M) | (23.21M) | (50.30M) | (29.31M) | (15.44M) | [{"date":"2020-06-30","value":-1644400000,"profit":false},{"date":"2021-06-30","value":-2321300000,"profit":false},{"date":"2022-06-30","value":-5030400000,"profit":false},{"date":"2023-06-30","value":-2931100000,"profit":false},{"date":"2024-06-30","value":-1544300000,"profit":false}] |
Income From Discontinued Operations | (20.79M) | (20.79M) | (20.79M) | (35.70M) | - | [{"date":"2020-06-30","value":-2079100000,"profit":false},{"date":"2021-06-30","value":-2079100000,"profit":false},{"date":"2022-06-30","value":-2079100000,"profit":false},{"date":"2023-06-30","value":-3569900000,"profit":false},{"date":"2024-06-30","value":"-","profit":true}] |
Net Income | (18.91M) | (23.26M) | (51.01M) | (29.31M) | (24.91M) | [{"date":"2020-06-30","value":-1891500000,"profit":false},{"date":"2021-06-30","value":-2325900000,"profit":false},{"date":"2022-06-30","value":-5100500000,"profit":false},{"date":"2023-06-30","value":-2931100000,"profit":false},{"date":"2024-06-30","value":-2490700000,"profit":false}] |
EPS (Diluted) | - | (4.20) | (5.71) | (3.33) | (6.42) | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":-420,"profit":false},{"date":"2022-06-30","value":-571,"profit":false},{"date":"2023-06-30","value":-333.32,"profit":false},{"date":"2024-06-30","value":-641.99,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
IBIO | |
---|---|
Cash Ratio | 3.18 |
Current Ratio | 3.37 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
IBIO | |
---|---|
ROA (LTM) | -29.73% |
ROE (LTM) | -84.15% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
IBIO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.28 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.72 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
IBIO | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 129.66 |
P/B | 1.28 |
Price/FCF | NM |
EV/R | 90.78 |
EV/Ebitda | NM |
PEG | NM |
Ibio Inc (IBIO) share price today is $2.36
Yes, Indians can buy shares of Ibio Inc (IBIO) on Vested. To buy Ibio Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Ibio Inc (IBIO) via the Vested app. You can start investing in Ibio Inc (IBIO) with a minimum investment of $1.
You can invest in shares of Ibio Inc (IBIO) via Vested in three simple steps:
The 52-week high price of Ibio Inc (IBIO) is $4.98. The 52-week low price of Ibio Inc (IBIO) is $1.02.
The price-to-earnings (P/E) ratio of Ibio Inc (IBIO) is
The price-to-book (P/B) ratio of Ibio Inc (IBIO) is 1.28
The dividend yield of Ibio Inc (IBIO) is 0.00%
The market capitalization of Ibio Inc (IBIO) is $23.30M
The stock symbol (or ticker) of Ibio Inc is IBIO